Steve Abella, MD
Chief Medical Officer
Steve is a pediatric hematologist oncologist who joined Bioclintherapeutics in 2017 as chief medical officer prior to that he was a Senior director for 4 years Gilead Sciences leading several oncology programs. Steve’s initial experience in industry began the he worked as executive director at Amgen for 4 years after 20 years of academic practice in pediatric hematology oncology with special expertise in stem cell transplantation.
Dr. Walensky is the recipient of numerous awards including a Stand Up to Cancer Innovative Research Grant, an NIH Director’s Transformative RO1 Award, a Burroughs Wellcome Career Award in the Biomedical Sciences, a Leukemia and Lymphoma Society Scholar Award, a Harvard Medical School Young Mentor Award, and most recently, the Dana-Farber Cancer Institute’s Morse Award for Research Excellence, the Samuel Rosenthal Prize for Excellence in Academic Pediatrics, the E. Mead Johnson Award for Pediatric Research, and an NCI Outstanding Investigator R35 Award. He is a member of the American Society for Clinical Investigation, the Society for Pediatric Research, and the American Pediatric Society.